Cited by 8Attention Deficit Hyperactivity DisorderEthics in Clinical ResearchNeuroethics, Human Enhancement, Biomedical Innovations

Molecular genetics research in ADHD: Ethical considerations concerning patients' benefit and resource allocation

Open access
Rothenberger, Lillian Geza·2012·American Journal of Medical Genetics Part B: Neuropsychiatric Genetics

Abstract

Immense resource allocations have led to great data output in genetic research. Concerning ADHD resources spent on genetic research are less than those spent on clinical research. But there are successful efforts made to increase support for molecular genetics research in ADHD. Concerning genetics no evidence based conclusive results have significant impact on prevention, diagnosis or treatment yet. With regard to ethical aspects like the patients' benefit and limited resources the question arises if it is indicated to think about a new balance of resource allocation between molecular genetics and non‐genetics research in ADHD. An ethical reflection was performed focusing on recent genetic studies and reviews based on a selective literature search. There are plausible reasons why genetic research results in ADHD are somehow disappointing for clinical practice so far. Researchers try to overcome these gaps systematically, without knowing what the potential future benefits for the patients might be. Non‐genetic diagnostic/therapeutic research may lead to clinically relevant findings within a shorter period of time. On the other hand, non‐genetic research in ADHD may be nurtured by genetic approaches. But, with the latter there exist significant risks of harm like stigmatization and concerns regarding data protection. Isolated speeding up resources of genetic research in ADHD seems questionable from an ethical point of view. There is a need to find a new balance of resource allocation between genetic and non‐genetic research in ADHD, probably by integrating genetics more systematically into clinical research. A transdisciplinary debate is recommended. © 2012 Wiley Periodicals, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajmg.b.32111

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ADHD is usually accompanied by other comorbid conditions, and patients with ADHD are frequently diagnosed with another neuropsychiatric condition, which can mask ADHD.

    “ADHD disorder is usually accompanied by other comorbid conditions. In fact, patients with ADHD are frequently diagnosed with another neuropsychiatric conditions, which can mask ADHD [71].”

    From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [71]

    In “A Brief Summary on ADHD” (page unavailable), the paper says comorbidities such as depression, anxiety, and conduct disorder are common in children with ADHD. It does not say that patients are frequently diagnosed with another condition or that such a diagnosis can mask ADHD, and its statement about comorbidity is limited to children. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 7

  1. D€ opfner M. 2006. ADHS im internationalen Vergleich: St€ orungsbild, Behandlungsoptionen und ethische Aspekte. In: Nationaler Ethikrat, editor. Tagungsdokumentation Pillen f€ urs Gl€ uck? € Uber den Umgang mit Depression und Hyperaktivit€ at. Berlin: Nationaler Ethikrat; pp 13-27 [English translation of the title and editor: ADHD in the international comparison: Symptoms, treatment options and ethical aspects. In: National Ethics Committee, editor. Conference documentation pills for the luck? About the coping with depression and hyperactivity].
  2. Fuchs C. 2011. Priorit€ aten setzen: Gerechte Leistungsverteilung muss offen diskutiert werden. Die derzeit praktizierte Leistungsbegrenzung in der medizinischen Versorgung ohne transparente Verteilungskriterien darf sich nicht fortsetzen. Eine Bilanz der Debatte € uber Rationierung und Priorit€ atensetzung aus € arztlicher Sicht. Dtsch Arztebl 108(24): A1356-A1359 [English translation of the title: Setting priorities: A just resource allocation has to be transparently discussed. The current limitation of resources in the health care system without transparent criteria of resource allocation must not continue. A balance of the debate on rationing and setting priorities from a medicine's point of view.].
  3. Leuzinger-Bohleber M. 2006. Psychoanalytische Erkundungen zu Depres- sion und Hyperaktivit€ at. Die emanzipatorisch-psychoanalytische Per- spektive. In: Nationaler Ethikrat, editors Tagungsdokumentation Pillen f€ urs Gl€ uck? € Uber den Umgang mit Depression und Hyperaktivit€ at. Berlin: Nationaler Ethikrat; pp. 61-71 [English translation of the title and editor: Psychoanalytical eruation concerning depression and hyper- activity. The emancipatoric-psychoanalytical perspective. In: National Ethics Committee, editor. Conference documentation Pills for the luck? About the coping with depression and hyperactivity].
  4. R€ otzer F. 2008. Taubes Designerbaby gew€ unscht. Britisches Paar fordert bei k€ unstlicher Befruchtung das Recht, Embryos, die nicht zur Taubheit veranlagt sind, auszusondern, weil beide Eltern taub sind. Press release 16 April. http://www.heise.de/tp/artikel/27/27720/1.html. Accessed August 4, 2011 [English translation of the title: Death designer baby wanted. Concerning artificial fertilization, British couple demands to have the right to withdrew embryos that are not going to be death later on as a child because both parents are death.].
  5. Schlander M, Trott G-E, Schwarz O. 2010a. Gesundheits€ okonomie der Aufmerksamkeitsdefizit-/Hyperaktivit€ atsst€ orung in Deutschland. Teil 1: Versorgungsepidemiologie und Krankheitskosten. Nervenarzt 81(3): 289-300 [English translation of the title: Health economy of ADHD in Germany. Part I: Health care epidemiology and costs of disease].
  6. Schlander M, Trott G-E, Schwarz O. 2010b. Gesundheits€ okonomie der Aufmerksamkeitsdefizit-/Hyperaktivit€ atsst€ orung in Deutschland. Teil 2: Therapeutische Optionen und ihre Kosteneffektivit€ at. Nervenarzt 81(3):301-314[English translation of the title: Health economy of ADHD in Germany. Part II: Treatment options and cost effectiveness.].
  7. Steinhausen H-C, Rothenberger A, D€ opfner M. 2010. Handbuch ADHS. Grundlagen, Klinik, Therapie und Verlauf der Aufmerksamkeitsdefizit- Hyperaktivit€ atsst€ orung. 1st edition. Stuttgart: Kohlhammer. 371 p. [English translation: Handbook ADHD. Basics, symptoms, treatment and prognosis of ADHD].

Cited by

Sorted by citations

Authors
Rothenberger, L. G.
Affiliations
University of Tübingen (DE)
Corresponding author
Rothenberger, Lillian Geza
Venue
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Publisher
Wiley
Published
2012-10-22
Volume
159B
Issue
8
Pages
885-895
ISSN
  • 1552-4841 (ISSN-L)
  • 1552-485X
OpenAlex
W2004561340
Cited by
8
References
67
Citations by year
2022: 1 · 2021: 5 · 2015: 1 · 2014: 1
FWCI
0.09
Type
journal article
Language
en
Open access
Locations
  • American Journal of Medical Genetics Part B Neuropsychiatric Genetics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
Keywords
attention deficit hyperactivity disorder, research ethics, resource allocation, patient benefit, genetic research funding, stigmatization, data protection, translational gap
MeSH terms
Attention Deficit Disorder with Hyperactivity, Health Priorities, Humans, Research, Genetic Predisposition to Disease, Ethics, Research, Diagnostic and Statistical Manual of Mental Disorders, Resource Allocation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review